newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Provides Long-Term Business Plan and Financial Guidance

CEO video / Q&A with shareholders on October 28, 2022 to review business plan and ballot items for special meeting of stockholders Acorda Therapeutics, Inc. (NASDAQ:ACOR) today provided a detailed, long-term